GeneTex is an internationally recognized research antibody manufacturer. Our antibodies are supported by extensive research, development and validation. We are committed to the highest standards of product performance, and our entire team is dedicated to the goal of accelerating your discovery. GeneTex was founded in early 1997 by three scientists with expertise in clinical oncology, cancer biolog
y and infectious disease. Based on their breadth of experience and research interests, the company's initial focus was breast cancer biology and prognostic marker research. This evolved to incorporate a comprehensive portfolio of immunological reagents used by scientists studying the fundamental mechanisms common to many forms of cancer. GeneTex’s product portfolio has since expanded to cover research areas including cell biology, epigenetics, immunology, infectious disease, metabolism, neuroscience, signal transduction, stem cell development and zebrafish biology. In 2009, GeneTex relocated from Texas to Irvine, California, which coincided with the construction of a state-of-the-art high-capacity manufacturing facility. By 2011, GeneTex had grown to become a multinational organization and one of the largest antibody manufacturers.
